The purpose of this IMDRF guidance is to harmonize the documentation and procedures that are 60 used to assess whether a medical device conforms to the regulations that apply in each jurisdiction. The worldwide adoption of fundamental design and manufacturing requirements for medical devices that, when met, provide assurance the device is safe and performs as intended, offers significant benefits to the manufacturer, user, patient or consumer, and to Regulatory Authorities. Eliminating differences between jurisdictions decreases the cost of gaining regulatory compliance and allows patients earlier access to new technologies and treatments.
News & Trends
Procurar
Recentes
- A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
- Electronic Submission Template for Premarket Approval Applications (PMAs)
- MDSAP Technical Review and Recognition Decision Procedure
- Essential Principles and Content of Predetermined Change Control Plans. Final Document
- Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
- GMP and GDP Question and Answer Guide Version 03 published by ECA
- Guideline on good pharmacovigilance practices (GVP) Module III – Pharmacovigilance inspections (Rev 2)
- Publication of COMBINE Project 2 Sponsors’ guide on safety reporting in combined studies

